Skip to main content

Table 4 Logistic regression analysis of clinical factors for clinically significant bleeding occurring with transbronchial cryobiopsy

From: Safety profile and risk factors for bleeding in transbronchial cryobiopsy using a two-scope technique for peripheral pulmonary lesions

Variable

Univariable analysis

Multivariable analysis

Incidence rate (%)

P value

OR (95% CI)

P value

Age (years)

 ≤ 70

8/57 (14.0)

0.37

  

 > 70

17/82 (20.7)

   

Sex

 Male

13/88 (14.8)

0.25

  

 Female

12/51 (23.5)

   

Body height (cm)

 ≤ 170

24/121 (19.8)

0.20

2.58 (0.29–23.30)

0.40

 > 170

1/18 (5.6)

   

Body mass index (kg/m2)

 ≤ 25

22/103 (21.4)

0.13

2.63 (0.62–11.10)

0.19

 > 25

3/36 (8.3)

   

Diameter of the lesion (mm)

 ≤ 20

10/47 (21.3)

0.49

  

 > 20

15/92 (16.3)

   

Lobar position

 Right upper lobe/left upper segment

13/70 (18.6)

1

  

 Right middle/left lingula

3/17 (17.6)

   

 Lower

9/52 (17.3)

   

Location area

 Inner area

9/53 (17.0)

1

  

 Outer area

16/86 (18.6)

   

Lesion appearance on CT

 GGN

17/36 (47.2)

< 0.001

9.30 (3.40–25.40)

 < 0.001

 Solid nodule

8/103 (7.8)

   

Bronchus sign

 Positive

18/104 (17.3)

0.8

  

 Negative

7/35 (20.0)

   

R-EBUS image

 Within

7/52 (13.5)

0.41

  

 Adjacent to

17/83 (20.5)

   

 Invisible

1/4 (25.0)

   

Chronic obstructive pulmonary disease

 Present

2/16 (12.5)

0.74

  

 Absent

23/123 (18.7)

   

Interstitial lung disease

 Present

1/6 (16.7)

1

  

 Absent

24/133 (18.0)

   

Bronchial asthma

 Present

1/6 (16.7)

1

  

 Absent

24/133 (18.0)

   

Using bridging anticoagulation therapy

 Present

1/5 (20.0)

1

  

 Absent

24/134 (17.9)

   

Cryoprobe size (mm)

 1.9

24/129 (18.6)

0.69

  

 2.4

1/10 (10.0)

   

Number of cryobiopsies taken

 1 biopsy

24/120 (20.0)

0.20

0.29 (0.032–2.69)

0.28

 ≥ 2 biopsies

1/19 (5.3)

   

Freezing time of cryobiopsy (s)

 ≤ 5

12/59 (20.3)

0.66

  

 > 5

13/80 (16.3)

   

Sample size (mm2)

 ≤ 15

15/103 (14.6)

0.084

0.5 (0.17–1.46)

0.21

 > 15

10/36 (27.8)

   
  1. OR odds ratio, CT computed tomography, GGN ground-glass nodule, R-EBUS radial endobronchial ultrasound